Healthcare Technology News

As the prevalence of diseases across the globe is increasing, the demand for effective drugs and treatments is growing as well. This is leading to the increasing number investments in the pharmaceutical & biopharmaceutical research & development. As per a publication by the Pharmaceuticals Research & Manufacturers of America, about $58.8 billion were spent by the member organizations of PhRMA on R&D activities, and the amount was the highest contribution to the biopharmaceutical R&D spending in the U.S. in 2015. A number of research and development activities in the pharmaceutical and biopharmaceutical industry make use of protein assays, which is leading to their increasing demand. To learn more about this report:  https://bit.ly/32ZXan1 These products are used in life science research for detecting the presence of protein in a sample, which is crucial for electrophoresis, atomic science, protein cleansing, cell science, and research applications. A wide variety of

In 2018, the global biosimilars market attained a value of $6 billion and is projected to register a 29.6% CAGR during the forecast period. The market is registering growth due to the inexpensive nature of biosimilar drugs, increasing geriatric population, rising research & development (R&D) investment by biopharmaceutical companies and extensive pipeline of biosimilars, and rising prevalence of chronic diseases. Generic equivalents of biologics are referred to as biosimilars. They are highly similar and comparable version of an approved biologic medicine and undergo clinical trials for demonstrating efficacy and safety. To learn more about this report:  https://bit.ly/2J9XVCh When technology is taken into consideration, the biosimilars market is divided into electrophoresis, monoclonal antibody (mAb), nuclear magnetic resonance, recombinant deoxyribonucleic acid, and bioassays. Out of these, the mAb technology dominated the market during the historical period 2014–2018 and is

The soaring global geriatric population, which is expected to reach at least 1.5 billion by 2050, according to the World Health Organization (WHO), is a key factor responsible for the rise in the demand for population health management (PHM). Elderly people require extensive care as they are more susceptible to diseases, especially chronic diseases, such as cancer and cardiovascular ailments, owing to their low immunity levels and high recovery periods. This causes a huge increase in the demand for better prevention, diagnosis, and treatment processes. In addition to this, older people also have a greater requirement for personalized medicine, because of their increased susceptibility to drug allergy, thereby boosting the demand for population health management . To learn more about this report:  https://bit.ly/3nMCHJo The other important factors bolstering the demand for PHM are the increasing healthcare expenditure, incentives, and investments by various governments throughout the wo

The rising incidence of chronic diseases, surging geriatric population, and increasing requirement of patient monitoring services, especially in the remote regions of the developing nations, are some of the major factors responsible for the wide-scale adoption of clinical decision support systems across the world. These systems are mainly required for streamlining the clinical procedures in these countries. According to a report published by the United Nations Department of Economic and Social Affairs (UNDESA), the share of the worldwide geriatric population is expected to increase from 11.7% of the global population in 2013 to 21.1% by the end of 2050. Driven by the above-mentioned factors, the global clinical decision support system market size is expected to exhibit tremendous growth in the coming years. The clinical decision support systems (CDSSs) are basically computer-based information systems that are used for assisting the medical practitioners in implementing clinical guidel

 Rapid technological developments in peptide utilization in the pharmaceutical industry are one of the biggest factors responsible for the rise in the demand for customized peptide synthesis across the world. Peptide has been conventionally produced from natural sources such as adrenocorticotropic hormone (ACTH) from bovine and porcine pituitary and insulin from canine and bovine pancreas. This production process was time-consuming and produced lower quantities of peptide. However, due to the technological advancements in the last few years, manufacturers have started shifting toward the synthesis of synthetic peptides such as octreotide, leuprorelin, and oxytocin. Driven by the above-mentioned factors, the valuation of the global customized peptide synthesis market size is predicted to increase from $268.8 million in 2018 to $390.0 million by 2024. The market is also expected to advance at a 6.4% CAGR during the forecast period (2019–2024). There are two types of products used in the

The prevalence of bleeding disorders is growing rapidly. Tale for instance the report by World Federation of Hemophilia, which stated that about 304,362 people across the globe are affected by different bleeding disorders, including von Willebrand disease and hemophilia. A bleeding disorder affects the way blood normally clots in human body. The clotting process, which is also known as coagulation, changed blood to a solid state from liquid. The process can be normally witnessed after an injury when the blood start clotting in order to prevent heavy loss of blood. However, some conditions prevent this clotting of blood and can lead to massive or prolonged bleeding. Request for sample copy of this report: https://www.psmarketresearch.com/market-analysis/blood-plasma-product-market/report-sample Bleeding disorders can result in abnormal bleeding both inside and outside the body and can increase the amount of blood leaving the body drastically. Owing to this growing prevalence of bleeding

 As per the Parkinson’s Disease Foundation, about 7–10 million people suffer from Parkinson’s disease, globally. In the U.S., each year, 60,000 new cases of Parkinson’s disease are reported. Further, epilepsy is one of the most common neurological disorders and affects people of all age groups. The World Health Organization said that about 50 million people across the world suffer from epilepsy, and about 2.4 million people are diagnosed with the condition every year. Chronic pain is associated with these diseases and many other conditions and may even be a result of injuries, which greatly affects the way of life. In a study conducted by the International Association for the Study of Pain, it was reported that about 2.8% of the total diabetic population suffered from peripheral neuropathic pain in 2000, and it is predicted to grow to 4.4% by 2030. To learn more about this report:  https://bit.ly/3kIMka1 A neurostimulation device is made of three basic components — a generator, leads,

The volume of surgical procedures is increasing all over the globe, which can be majorly ascribed to the surging geriatric population, rising prevalence of chronic and lifestyle-associated diseases, and growing cases of injuries due to burns and road accidents. When a disease or wound cannot be treated using medication, a person has to go through a surgical procedure. In addition to this, people are increasingly becoming conscious regarding their physical appearance, owing to which, the number of cosmetic surgical procedures has risen as well. This growing volume of surgeries is among the major factors that are leading to the rising demand for surgical sutures. Sutures, also known as stiches, are sterile surgical threads which are utilized for repairing cuts and for closing incisions from surgery. These medical devices make sure that the skin, blood vessels, internal organs, and other tissues are held together after an injury, surgery, or incision. Sutures holds tissues together until

One of the major factors fuelling the demand for wound care solutions is the increasing prevalence of burn cases across the globe. Burns caused because of various factors such as electricity, radiation, friction, chemicals, and heat often lead to loss of skink, blood vessels, and tissue. “As per a report published by the National Fire Protection Association (NFPA), the total number of fire-related wounds and injuries in the U.S. in 2014 was 15,775”. “The other important factor responsible for the soaring sales of wound care products is the surging incidence of road throughout the world”. “According to a report produced by the World Health Organization (WHO) in 2016, 20—50 million people all over the world suffer from various types of non-fatal wounds and injuries because of road accidents every year”. The wounds caused due to car crashes are exposed to microbes, soil, debris, and dust. Moreover, the tissue loss caused in road injuries takes a lot of time to heal, which, in turn, increa

The prevalence of chronic, lifestyle-associated, and respiratory diseases is on the rise across the world. For example, as per the Centers for Disease Control and Prevention (CDC), about 117 million people in the U.S. were suffering from at least one chronic disease in 2012. Similarly, according to the World Health Organization, nearly 250,000 people die of asthma every year around the world. In order to treat these diseases, several medical gases and devices are required. Hence, as the prevalence of various diseases increases, the demand for all types of medical devices will also grow. Medical gases and equipment are important elements in medical centers, life sciences sector, laboratories, and long-term care; they are used for treatment as well as diagnosis of several diseases. Download sample copy of this report:  https://www.psmarketresearch.com/market-analysis/medical-gases-and-equipment-market/report-sample According to a study conducted by the P&S Intelligence, the global me

The food & beverages industry is expected to grow at a considerable pace in the years to come, which is because of the changing consumer preferences, strong economic growth in emerging economies, and rapid urbanization. In addition to this, fast food and processed food items are becoming increasingly popular across the globe. The industry deals with the sensitive production processes and therefore needs to take utmost care when it comes to the safety of food. In order to ensure that different food and beverage items are free from contaminants and fit for consumptions, the industry makes extensive use of different laboratory filtration products. To learn more about this report:  https://bit.ly/38sjgB3 Different types of filtration products and filtration technologies are used on the basis of objectives and conditions of an analytical procedure or experiment. Attributed to this, the global laboratory filtration market is predicted to attain $3.5 billion by 2023, increasing from $2.3

Valued at $192.0 billion in 2018, the global complementary and alternative medicines market is predicted to reach a value of $271.8 billion in 2024, progressing at a CAGR of 6.0% from 2019 to 2024. The major factors fueling the advancement of the market are the increasing utilization of traditional therapies and medicines, growing geriatric population, adoption of unhealthy lifestyles, the various side-effects and risks usually associated with allopathic medicines, and the increasing frequency of product launches by the market players. To learn more about this report:  https://bit.ly/32tysdn The adoption of unhealthy lifestyles has drastically increased the incidence of various chronic diseases and ailments such as stress, obesity, hypertension, and insomnia. Therefore, many organizations are increasingly evaluating the potential of alternative medicines in treating these medical conditions. As per Our World in Data, in 2017, 3.4% and 3.8% of the global population were found to suffer